Ankylosing spondylitis (AS) is a progressive inflammatory disease of the axial skeleton characterized by chronic back pain, stiffness, and potential spinal fusion. The condition is often managed with ...
Everyday Health on MSN
8 Things People With Ankylosing Spondylitis Should Know About the COVID-19 Vaccines
People with a rheumatoid condition such as AS have no special contraindications that could keep them from receiving the COVID-19 vaccine.
Patients with ankylosing spondylitis (AS) may require biological therapy, particularly tumour necrosis factor (TNF) inhibitors, which are effective but increase the risk of tuberculosis (TB).
MedPage Today on MSN
Spondyloarthritis Treatment in Canada Falls Well Short of Ideal
Multiple TNF inhibitors, as well as interleukin-17 blockers such as secukinumab (Cosentyx) and Janus kinase (JAK) inhibitors ...
Treatment with TNFi was associated with increased adherence and drug survival when compared with IL-17i and JAKi in patients with ankylosing spondylitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback